Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 2216-2223, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wassell, J.
Right arrow Articles by Weinkove, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wassell, J.
Right arrow Articles by Weinkove, C.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:2216-2223.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Freedom from Drug Interference in New Immunoassays for Urinary Catecholamines and Metanephrines

Julie Wassell1,a, Paul Reed2, John Kane2 and Cyril Weinkove2

1 Department of Biochemistry, Wythenshawe Hospital, Southmoor Rd., Manchester M23 9LT, UK.

2 Department of Biochemistry, Hope Hospital, Stott Lane, Manchester M6 8HD, UK.
a Author for correspondence. Fax 0161-291-2125; e-mail juliewassell{at}hotmail.com

Background: Determination of urinary free catecholamine and total (i.e., free plus conjugated) metanephrine excretion is considered the most clinically sensitive biochemical test for pheochromocytoma. In this study, we evaluated new immunoassay methods for the measurement of these analytes for potential drug-based interference.

Methods: Urine samples collected from patients on a variety of medications were grouped by specific drug type. The significance of any difference in the free catecholamine or total metanephrine concentrations in the different groups was assessed by one-way ANOVA. A group of patients receiving no medication was included as a control (no analytical interference). Additionally, analytical accuracy, detection limit, and precision were determined.

Results: No significant differences were found in the concentrations of free catecholamines or total metanephrines in urine from patients taking the medications investigated and the control group: P = 0.649 (fE), 0.221 (fNE), 0.149 (tM), and 0.170 (tNM). For free catecholamines, intraassay CVs were 4.6–18%; interassay CVs were 10–25%. For total metanephrines, intraassay CVs were 9.6–27%; interassay CVs were 5.8–22%. Detection limits were 0.009 and 0.027 µmol/L for fE and fNE and 0.119 and 0.346 µmol/L for tM and tNM, respectively.

Conclusions: None of the drugs examined in this study interfered in the measurement of free catecholamines or total metanephrines by these immunoassays. The technique is easier to use, requires less equipment, and is more accessible than HPLC. In combination, these assays are suitable as initial screening tests for pheochromocytoma.




The following articles in journals at HighWire Press have cited this article:


Home page
 Eur J EndocrinolHome page
M. d'Herbomez, G. Forzy, C. Bauters, C. Tierny, P. Pigny, B. Carnaille, F. Pattou, J.-L. Wemeau, and N. Rouaix
An analysis of the biochemical diagnosis of 66 pheochromocytomas
Eur. J. Endocrinol., May 1, 2007; 156(5): 569 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
K. L. Brain, J. Kay, and B. Shine
Measurement of Urinary Metanephrines to Screen for Pheochromocytoma in an Unselected Hospital Referral Population
Clin. Chem., November 1, 2006; 52(11): 2060 - 2064.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
I. Charalampopoulos, E. Dermitzaki, L. Vardouli, C. Tsatsanis, C. Stournaras, A. N. Margioris, and A. Gravanis
Dehydroepiandrosterone Sulfate and Allopregnanolone Directly Stimulate Catecholamine Production via Induction of Tyrosine Hydroxylase and Secretion by Affecting Actin Polymerization
Endocrinology, August 1, 2005; 146(8): 3309 - 3318.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. L. Taylor and R. J. Singh
Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Analysis of Urinary Conjugated Metanephrine and Normetanephrine for Screening of Pheochromocytoma
Clin. Chem., March 1, 2002; 48(3): 533 - 539.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.